GAS5 and hepatocellular carcinoma: Collectively, these findings suggest that GAS5 exerts an inhibitory effect on HCC tumorigenesis and progression, while also enhancing the sensitivity of HCC cells to drugs such as sorafenib, doxorubicin, and cisplatin.